S. Rasmussen

Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.

G Chouinard, Wayne K. Goodman, John H. Greist et al. · PubMed · 1990 · 136 citations

Medicine, Pharmacology, Pharmacotherapy +11

A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder

John H. Greist, James W. Jefferson, Kenneth A. Kobak et al. · International Clinical Psychopharmacology · 1995 · 132 citations

Medicine, Pharmacotherapy, Psychiatry +13

Paroxetine in the treatment of depression ‐ a randomized comparison with amitriptyline

Alex Lund Laursen, P. L. Mikkelsen, S. Rasmussen et al. · Acta Psychiatrica Scandinavica · 1985 · 85 citations

Medicine, Pharmacology, Pharmacotherapy +12

The Panic‐Associated Symptom Scale: measuring the severity of panic disorder

Nick Argyle, Joseph Deltito, Peter Allerup et al. · Acta Psychiatrica Scandinavica · 1991 · 64 citations

Social Sciences, Psychiatry, Psychology +17

Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.

Joseph DeVeaugh-Geiss, Richard J. Katz, Phyllis Landau et al. · PubMed · 1990 · 47 citations

Medicine, Pharmacotherapy, Psychiatry +12